OverviewSuggest Edit

stimOS is a company that develops a patented mimicking bone technology created to transform implant surfaces from an artificial barrier into a bone identical implant body interface. Its mimicking bone technology is a biochemical procedure that initiates early and healthy bone formation, anti-inflammatory activity, and fast healing process, enabling patients to get required possible recovery and achieve a pain-free life after surgery.
TypePrivate
Founded2015
Websitesmartimplants.net

Latest Updates

Employees (est.) (Apr 2021)4
Cybersecurity ratingAMore

stimOS Financials and Metrics

Summary Metrics

Founding Date

2015

stimOS total Funding

$839.5 k

Time since last funding

9 months ago

stimOS investors

Show all financial metrics

stimOS Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

stimOS Online and Social Media Presence

Embed Graph

stimOS News and Updates

stimOS Raises Series A Funding Round

stimOS GmbH, a Constance, Germany-based medical technology company, raised a a Series A funding round of undisclosed amount. WEFA Inotec GmbH, a German market leader in extrusion tooling, precision technology and CVD coatings, participated in the round, along with HTGF, MBG and founding partner Diet…

stimOS Frequently Asked Questions

  • When was stimOS founded?

    stimOS was founded in 2015.

  • How many employees does stimOS have?

    stimOS has 4 employees.

  • Who are stimOS competitors?

    Competitors of stimOS include Fortimedix, Prescient Surgical and Procardia Medical.